chr11-115209591-ATGGTGGTGG-A
Position:
Variant summary
Our verdict is Benign. Variant got -13 ACMG points: 0P and 13B. BP3BP6_Very_StrongBS2
The NM_001301043.2(CADM1):βc.1052_1060delβ(p.Thr351_Thr353del) variant causes a inframe deletion change. The variant allele was found at a frequency of 0.000772 in 924,982 control chromosomes in the GnomAD database, including 1 homozygotes. Variant has been reported in ClinVar as Benign (β β ).
Frequency
Genomes: π 0.00056 ( 0 hom., cov: 32)
Exomes π: 0.00081 ( 1 hom. )
Consequence
CADM1
NM_001301043.2 inframe_deletion
NM_001301043.2 inframe_deletion
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 6.96
Genes affected
CADM1 (HGNC:5951): (cell adhesion molecule 1) Enables signaling receptor binding activity. Involved in several processes, including cell recognition; positive regulation of cytokine production; and susceptibility to natural killer cell mediated cytotoxicity. Located in plasma membrane. Implicated in breast carcinoma and prostate cancer. Biomarker of cervix uteri carcinoma in situ. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -13 ACMG points.
BP3
Nonframeshift variant in repetitive region in NM_001301043.2
BP6
Variant 11-115209591-ATGGTGGTGG-A is Benign according to our data. Variant chr11-115209591-ATGGTGGTGG-A is described in ClinVar as [Benign]. Clinvar id is 733505.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS2
High AC in GnomAd4 at 78 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CADM1 | NM_001301043.2 | c.1052_1060del | p.Thr351_Thr353del | inframe_deletion | 8/12 | ENST00000331581.11 | NP_001287972.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CADM1 | ENST00000331581.11 | c.1052_1060del | p.Thr351_Thr353del | inframe_deletion | 8/12 | 1 | NM_001301043.2 | ENSP00000329797 | P4 |
Frequencies
GnomAD3 genomes AF: 0.000547 AC: 76AN: 139038Hom.: 0 Cov.: 32
GnomAD3 genomes
AF:
AC:
76
AN:
139038
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00122 AC: 259AN: 212678Hom.: 1 AF XY: 0.00123 AC XY: 142AN XY: 115448
GnomAD3 exomes
AF:
AC:
259
AN:
212678
Hom.:
AF XY:
AC XY:
142
AN XY:
115448
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000809 AC: 636AN: 785820Hom.: 1 AF XY: 0.000845 AC XY: 346AN XY: 409302
GnomAD4 exome
AF:
AC:
636
AN:
785820
Hom.:
AF XY:
AC XY:
346
AN XY:
409302
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000560 AC: 78AN: 139162Hom.: 0 Cov.: 32 AF XY: 0.000742 AC XY: 50AN XY: 67384
GnomAD4 genome
AF:
AC:
78
AN:
139162
Hom.:
Cov.:
32
AF XY:
AC XY:
50
AN XY:
67384
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Bravo
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Jul 01, 2024 | CADM1: BS1, BS2 - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Dec 31, 2019 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at